BR100 Decreased By (-0.55%)
BR30 Decreased By (-0.77%)
KSE100 Decreased By (-0.37%)
KSE30 Decreased By (-0.31%)
AGHA 6.56 Decreased By ▼ -0.11 (-1.65%)
BECO 4.40 Increased By ▲ 0.05 (1.15%)
BML 55.25 Decreased By ▼ -0.92 (-1.64%)
BOP 29.89 Decreased By ▼ -0.23 (-0.76%)
CNERGY 12.69 Decreased By ▼ -0.29 (-2.23%)
CSIL 5.21 Decreased By ▼ -0.10 (-1.88%)
FCCL 51.20 Decreased By ▼ -0.45 (-0.87%)
FFL 14.38 Decreased By ▼ -0.11 (-0.76%)
FNEL 1.18 Decreased By ▼ -0.03 (-2.48%)
KEL 5.98 Decreased By ▼ -0.08 (-1.32%)
KOSM 5.55 Decreased By ▼ -0.29 (-4.97%)
LOTCHEM 26.16 Decreased By ▼ -0.01 (-0.04%)
MLCF 90.00 Decreased By ▼ -1.23 (-1.35%)
NBP 162.49 Decreased By ▼ -1.70 (-1.04%)
NCPL 52.69 Decreased By ▼ -0.49 (-0.92%)
NPL 57.88 Decreased By ▼ -1.24 (-2.1%)
OGDC 314.00 Increased By ▲ 0.61 (0.19%)
PACE 9.69 Decreased By ▼ -0.08 (-0.82%)
PAEL 34.90 Decreased By ▼ -0.34 (-0.96%)
PIBTL 14.16 Decreased By ▼ -0.55 (-3.74%)
PPL 219.60 Decreased By ▼ -1.76 (-0.8%)
PRL 90.03 Decreased By ▼ -1.19 (-1.3%)
PTC 58.90 Decreased By ▼ -0.29 (-0.49%)
SSGC 23.20 Decreased By ▼ -0.10 (-0.43%)
TBL 8.68 Decreased By ▼ -0.07 (-0.8%)
TELE 7.35 Decreased By ▼ -0.26 (-3.42%)
TPL 21.10 Decreased By ▼ -0.93 (-4.22%)
TPLP 12.08 Decreased By ▼ -0.48 (-3.82%)
TREET 21.35 Decreased By ▼ -0.38 (-1.75%)
TRG 54.47 Decreased By ▼ -1.32 (-2.37%)
Life & Style

Fender stock buyers will gently weep

Published Updated

FenderNEW YORK: The iconic maker of guitars favored by Clapton and Hendrix is riffing on an IPO valuation of 20 times earnings. But Fender has questionable global expansion plans, depends on a big shaky customer and generates only pick-thin margins. There's too much to make investors fret.

Fender Musical Instruments on July 9 set a price range of between $13 and $15 a share for its initial public offering. The guitar maker would be valued at $395 million at the top end of the range. Private equity firm Weston Presidio is selling 3.5 million shares, decreasing its ownership stake from 43 percent to about 18 percent.

Copyright Reuters, 2012

Comments

Comments are closed for this article.